Previous 10 | Next 10 |
Dario Contracts with New Employer for Cardiometabolic Solution PR Newswire Demand for Dario's integrated cardiometabolic solution continues to grow as employers grappling with the surge in GLP-1 medication utilization search for proven ways to change health behaviors ...
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, today announced two new analyses presented by Sanofi U.S. demonstrating two mediators associated with improved clinical and economic results in Dario users. According to the announcement, presentations by Sanofi U.S. at th...
New Research Sheds Light on Mediators of Improved Outcomes in Dario Users PR Newswire Two new analyses associate improved clinical and economic outcomes with use of Dario's digital health solution NEW YORK , Nov. 21, 2023 /PRNewswire/ -- DarioHealth Corp....
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, is reporting on new research presented last week at the Diabetes Technology Society 2023 Meeting. According to the announcement, the new study demonstrates the value of associating physical activity tracking alongside bloo...
Dario Publishes New Research Demonstrating that Dario Users That Increased Physical Activity Can Maintain Reduced Blood Glucose PR Newswire New study highlights the value of a whole health approach managing chronic conditions and supporting members using GLP-1s NEW Y...
2023-11-03 12:39:12 ET Gainers: Cooper-Standard Holdings CPS +42% . Udemy UDMY +37% . DarioHealth Corp ( DRIO ) +37% . Qurate Retail QRTEP +29% . Enlivex Therapeutics Ltd ( ENLV ) +28% . Redfin Corp RDFN +28% . Figs FIGS +27% ...
2023-11-02 13:15:49 ET More on etc. Dynatrace, Inc. (DT) Q2 2024 Earnings Call Transcript Geron Corporation 2023 Q3 - Results - Earnings Call Presentation Gates Industrial: Encouraging Q3 Report Needed To Finally Create A Floor For The Stock Icahn Enterprises...
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, today announced financial results for the third quarter 2023 and provided a corporate and commercial update. “As we discussed during our recent investor day, our revenue generally comes from three sources, our histo...
2023-11-02 07:27:53 ET More on DarioHealth DarioHealth Disappoints, But A Better Future Is Ahead DarioHealth GAAP EPS of -$0.58 misses by $0.06, revenue of $6.15M beats by $0.14M Seeking Alpha’s Quant Rating on DarioHealth For further details see: ...
Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...
News, Short Squeeze, Breakout and More Instantly...
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, is planning to release its financial results for the second quarter 2024, covering the period ended June 30, 2024. According to the announcement, the company will release the report on Aug. 8, 2024, before the market opens...
DarioHealth to Report Second Quarter 2024 Results on Thursday, August 8th PR Newswire Company to host conference call and webcast at 8:30am ET NEW YORK , July 30, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital th...
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, today announced a new contract with a national employer to provide its cardiometabolic solution with integrated support for GLP-1s to employees beginning in the third quarter of 2024. “The challenges associated with...